FDA Determines Regulatory Review Period for ENDEAVOR Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for ENDEAVOR, a medical device patent extension application submitted to the Department of Commerce, as required by law.